Skip to main content
SpringerLink
Log in

Female Genital Tract

  • Chapter
  • First Online:
Cytopathology in Oncology

Part of the book series: Cancer Treatment and Research ((CTAR,volume 160))

  • 1717 Accesses

Abstract

This chapter provides an overview of cervical cancer screening by cervical vaginal cytology including pathogenesis of cervical cancer, the role of HPV testing, methods for obtaining the cytology sample and a review of the latest guidelines for screening. The chapter also reviews cytology of the endometrium, the adnexa and the use of pelvic washing.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bosch FX, Burchell AN, Schiffman M et al (2008) Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 26(Suppl 10):K1–K16

    Article  PubMed  Google Scholar 

  2. Dunne EF, Unger ER, Sternberg M et al (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813–819

    Article  PubMed  CAS  Google Scholar 

  3. Munoz N, Bosch FX, de Sanjose S et al (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527

    Article  PubMed  Google Scholar 

  4. Wright TC Jr, Schiffman M (2003) Adding a test for human papillomavirus DNA to cervical-cancer screening. N Engl J Med 348:489–490

    Article  PubMed  Google Scholar 

  5. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29

    Article  PubMed  Google Scholar 

  6. Wellings K, Collumbien M, Slaymaker E et al (2006) Sexual behaviour in context: a global perspective. Lancet 368:1706–1728

    Article  PubMed  Google Scholar 

  7. Sirovich BE, Welch HG (2004) The frequency of Pap smear screening in the United States. J Gen Intern Med 19:243–250

    Article  PubMed  Google Scholar 

  8. Diamantis A, Magiorkinis E, Androutsos G (2009) What’s in a name? Evidence that Papanicolaou, not Babes, deserves credit for the PAP test. Diagn Cytopatho l38(7):473–476)

    Google Scholar 

  9. Janerich DT, Hadjimichael O, Schwartz PE et al (1995) The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health 85:791–794

    Article  PubMed  CAS  Google Scholar 

  10. Koliopoulos G, Arbyn M, Martin-Hirsch P, Kyrgiou M, Prendiville W, Paraskevaidis E (2007) Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies. Gynecol Oncol 104:232–246

    Article  PubMed  Google Scholar 

  11. Wright TC Jr (2003) Cervical cancer screening using visualization techniques. J Natl Cancer Inst Monogr 31:66–71

    Google Scholar 

  12. Marchand L, Mundt M, Klein G, Agarwal SC (2005) Optimal collection technique and devices for a quality pap smear. WMJ 104:51–55

    PubMed  Google Scholar 

  13. Martin-Hirsch P, Jarvis G, Kitchener H, Lilford R (2000) Collection devices for obtaining cervical cytology samples. Cochrane Database Syst Rev 2:CD001036

    Google Scholar 

  14. Ferris DG, Berrey MM, Ellis KE, Petry LJ, Voxnaes J, Beatie RT (1992) The optimal technique for obtaining a Papanicolaou smear with the Cervex-Brush. J Fam Pract 34:276–280

    PubMed  CAS  Google Scholar 

  15. Harrison DD, Hernandez E, Dunton CJ (1993) Endocervical brush versus cotton swab for obtaining cervical smears at a clinic. A cost comparison. J Reprod Med 38:285–288

    PubMed  CAS  Google Scholar 

  16. Arbyn M, Herbert A, Schenck U et al (2007) European guidelines for quality assurance in cervical cancer screening: recommendations for collecting samples for conventional and liquid-based cytology. Cytopathology 18:133–139

    Article  PubMed  CAS  Google Scholar 

  17. Day SJ, O’Shaughnessy DL, O’Connor JC, Freund GG (2004) Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility. BMC Womens Health 4:6

    Article  PubMed  Google Scholar 

  18. Solomon D, Nayar R (2004) The Bethesda System for reporting cervical cytology. Springer, New York

    Google Scholar 

  19. Barr Soofer S, Sidawy MK (1997) Reactive cellular change: is there an increased risk for squamous intraepithelial lesions? Cancer 81:144–147

    Google Scholar 

  20. Malik SN, Wilkinson EJ, Drew PA, Hardt NS (2001) Benign cellular changes in Pap smears: causes and significance. Acta Cytol 45:5–8

    Article  PubMed  CAS  Google Scholar 

  21. Moriarty AT, Young NA (2003) The four R’s: reactive/repair, reporting, and regulations. Diagn Cytopathol 29:1–3

    Article  PubMed  Google Scholar 

  22. Tambouret R, Pitman MB, Bell DA (1998) Benign glandular cells in posthysterectomy vaginal smears. Acta Cytol 42:1403–1408

    Article  PubMed  CAS  Google Scholar 

  23. Bean SM, Connolly K, Roberson J, Eltoum I, Chhieng DC (2006) Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System. Cancer 108:39–44

    Article  PubMed  Google Scholar 

  24. Chang A, Sandweiss L, Bose S (2001) Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women. Gynecol Oncol 80:37–43

    Article  PubMed  CAS  Google Scholar 

  25. Gray JA, Nguyen GK (1999) Cytologic detection of endometrial pathology by Pap smears [letter]. Diagn Cytopathol 20:181–182

    Article  PubMed  CAS  Google Scholar 

  26. Nguyen TN, Bourdeau JL, Ferenczy A, Franco EL (1998) Clinical significance of histiocytes in the detection of endometrial adenocarcinoma and hyperplasia. Diagn Cytopathol 19:89–93

    Article  PubMed  CAS  Google Scholar 

  27. Tambouret R, Bell DA, Centeno BA (2001) Significance of histiocytes in cervical smears from peri/postmenopausal women. Diagn Cytopathol 24:271–275

    Article  PubMed  CAS  Google Scholar 

  28. Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F (1999) ThinPrep Pap Test: accuracy for glandular disease. Acta Cytol 43:81–85

    Article  PubMed  CAS  Google Scholar 

  29. Bose S, Kannan V, Kline TS (1994) Abnormal endocervical cells. Really abnormal? Really endocervical? Am J Clin Pathol 101:708–713

    PubMed  CAS  Google Scholar 

  30. DiTomasso JP, Ramzy I, Mody DR (1996) Glandular lesions of the cervix. Validity of cytologic criteria used to differentiate reactive changes, glandular intraepithelial lesions and adenocarcinoma. Acta Cytol 40:1127–1135

    Article  PubMed  CAS  Google Scholar 

  31. Betsill WL Jr, Clark AH (1986) Early endocervical glandular neoplasia. I. Histomorphology and cytomorphology. Acta Cytol 30:115–126

    PubMed  Google Scholar 

  32. Lee KR, Minter LJ, Granter SR (1997) Papanicolaou smear sensitivity for adenocarcinoma in situ of the cervix. A study of 34 cases. Am J Clin Pathol 107:30–35

    PubMed  CAS  Google Scholar 

  33. Drijkoningen M, Meertens B, Lauweryns J (1996) High grade squamous intraepithelial lesion (CIN 3) with extension into the endocervical clefts. Difficulty of cytologic differentiation from adenocarcinoma in situ. Acta Cytol 40:889–894

    Article  PubMed  CAS  Google Scholar 

  34. Selvaggi SM (2002) Cytologic features of high-grade squamous intraepithelial lesions involving endocervical glands on ThinPrep cytology. Diagn Cytopathol 26:181–185

    Article  PubMed  Google Scholar 

  35. Gupta D, Balsara G (1999) Extrauterine malignancies. Role of Pap smears in diagnosis and management. Acta Cytol 43:806–813

    Article  PubMed  CAS  Google Scholar 

  36. Belsley NA, Tambouret RH, Misdraji J, Muzikansky A, Russell DK, Wilbur DC (2008) Cytologic features of endocervical glandular lesions: comparison of SurePath, ThinPrep, and conventional smear specimen preparations. Diagn Cytopathol 36:232–237

    Article  PubMed  Google Scholar 

  37. Hanley KZ, Tadros TS, Briones AJ, Birdsong GG, Mosunjac MB (2009) Hematologic malignancies of the female genital tract diagnosed on liquid-based Pap test: cytomorphologic features and review of differential diagnoses. Diagn Cytopathol 37:61–67

    Article  PubMed  Google Scholar 

  38. Pasternak S, MacIntosh R (2006) Uterine adenosarcoma detected by Papanicolaou smear: a case report. Diagn Cytopathol 34:495–498

    Article  PubMed  Google Scholar 

  39. McGill F, Adachi A, Karimi N et al (1990) Abnormal cervical cytology leading to the diagnosis of gastric cancer. Gynecol Oncol 36:101–105

    Article  PubMed  CAS  Google Scholar 

  40. McCluggage WG, Hurrell DP, Kennedy K (2010) Metastatic carcinomas in the cervix mimicking primary cervical adenocarcinoma and adenocarcinoma in situ: report of a series of cases. Am J Surg Pathol 34:735–741

    PubMed  Google Scholar 

  41. Reid R, Greenberg MD, Lorincz A et al (1991) Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 164:14611469; discussion 9–71

    Google Scholar 

  42. Cox JT, Schiffman MH, Winzelberg AJ, Patterson JM (1992) An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol 80:389–395

    PubMed  CAS  Google Scholar 

  43. Manos MM, Kinney WK, Hurley LB et al (1999) Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results [see comments]. JAMA 281:1605–1610

    Article  PubMed  CAS  Google Scholar 

  44. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 92:397–402 (2000)

    Google Scholar 

  45. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ (2002) 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287:2120–2129

    Article  PubMed  Google Scholar 

  46. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D (2007) 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 197:346–355

    Article  PubMed  Google Scholar 

  47. Kitchener HC, Almonte M, Wheeler P et al (2006) HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 95:56–61

    Article  PubMed  CAS  Google Scholar 

  48. Naucler P, Ryd W, Tornberg S et al (2007) Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357:1589–1597

    Article  PubMed  CAS  Google Scholar 

  49. Mayrand MH, Duarte-Franco E, Rodrigues I et al (2007) Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357:1579–1588

    Article  PubMed  CAS  Google Scholar 

  50. Ronco G, Giorgi-Rossi P, Carozzi F et al (2010) Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 11:249–257

    Article  PubMed  CAS  Google Scholar 

  51. Kulasingam SL, Havrilesky L, Ghebre R, Myers ER (2011) Screening for cervical cancer: a decision analysis for the U.S. Preventive Services Task Force [Internet]. Agency for Healthcare Research and Quality (US), Rockville

    Google Scholar 

  52. Saslow D, Solomon D, Lawson HW et al (2012) American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 137:516–542

    Article  PubMed  Google Scholar 

  53. Lyamichev V, Brow MA, Dahlberg JE (1993) Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases. Science 260:778–783

    Article  PubMed  CAS  Google Scholar 

  54. Hsu TM, Law SM, Duan S, Neri BP, Kwok PY (2001) Genotyping single-nucleotide polymorphisms by the invader assay with dual-color fluorescence polarization detection. Clin Chem 47:1373–1377

    PubMed  CAS  Google Scholar 

  55. Stillman MJ, Day SP, Schutzbank TE (2009) A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus. J Clin Virol 45(Suppl 1):S73–S77

    Article  PubMed  CAS  Google Scholar 

  56. Johnson LR, Starkey CR, Palmer J et al (2008) A comparison of two methods to determine the presence of high-risk HPV cervical infections. Am J Clin Pathol 130:401–408

    Article  PubMed  Google Scholar 

  57. Ginocchio CC, Barth D, Zhang F (2008) Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA. J Clin Microbiol 46:1641–1646

    Article  PubMed  CAS  Google Scholar 

  58. Bartholomew DA, Luff RD, Quigley NB, Curtis M, Olson MC (2011) Analytical performance of Cervista HPV 16/18 genotyping test for cervical cytology samples. J Clin Virol 51:38–43

    Article  PubMed  CAS  Google Scholar 

  59. Einstein MH, Martens MG, Garcia FA et al (2010) Clinical validation of the Cervista HPV HR and 16/18 genotyping tests for use in women with ASC-US cytology. Gynecol Oncol 118:116–122

    Article  PubMed  Google Scholar 

  60. Cuzick J, Arbyn M, Sankaranarayanan R et al (2008) Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 26(Suppl 10):K29–K41

    Article  PubMed  Google Scholar 

  61. Rozendaal L, Walboomers JM, van der Linden JC et al (1996) PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 68:766–769

    Article  PubMed  CAS  Google Scholar 

  62. Walboomers JM, Jacobs MV, Manos MM et al (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19

    Article  PubMed  CAS  Google Scholar 

  63. de Sanjose S, Quint WG, Alemany L et al (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056

    Article  PubMed  CAS  Google Scholar 

  64. Castle PE, Porras C, Quint WG et al (2008) Comparison of two PCR-based human papillomavirus genotyping methods. J Clin Microbiol 46:3437–3445

    Article  PubMed  CAS  Google Scholar 

  65. Castle PE, Sadorra M, Lau T, Aldrich C, Garcia FA, Kornegay J (2009) Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin Microbiol 47:3344–3347

    Article  PubMed  Google Scholar 

  66. Heideman DA, Hesselink AT, Berkhof J et al (2011) Clinical validation of the cobas 4800 HPV test for cervical screening purposes. J Clin Microbiol 49:3983–3985

    Article  PubMed  CAS  Google Scholar 

  67. Lapierre SG, Sauthier P, Mayrand MH et al (2012) Human papillomavirus (HPV) DNA triage of women with atypical squamous cells of undetermined significance with cobas 4800 HPV and Hybrid Capture 2 tests for detection of high-grade lesions of the uterine cervix. J Clin Microbiol 50:1240–1244

    Article  PubMed  Google Scholar 

  68. Martinez SB, Palomares JC, Artura A et al (2012) Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples. J Virol Methods 180:7–10

    Article  PubMed  CAS  Google Scholar 

  69. Lindemann ML, Dominguez MJ, de Antonio JC et al (2012) Analytical comparison of the cobas HPV Test with Hybrid Capture 2 for the detection of high-risk HPV genotypes. J Mol Diagn 14:65–70

    Article  PubMed  Google Scholar 

  70. Gage JC, Sadorra M, Lamere BJ et al (2012) Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests. J Clin Microbiol 50:61–65

    Article  PubMed  Google Scholar 

  71. Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens C, Wright TL (2011) Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results. Am J Clin Pathol 136:578–586

    Article  PubMed  Google Scholar 

  72. Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL (2011) High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study. Am J Clin Pathol 135:468–475

    Article  PubMed  Google Scholar 

  73. Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM (2011) Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol 12:880–890

    Article  PubMed  Google Scholar 

  74. Stoler MH, Wright TC Jr Sharma A et al (2012) The interplay of age stratification and HPV testing on the predictive value of ASC-US cytology. Results from the ATHENA HPV study. Am J Clin Pathol 137:295–303

    Article  PubMed  Google Scholar 

  75. Cox JT, Castle PE, Behrens CM, Sharma A, Wright TC Jr, Cuzick J (2013) Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol 208(3):e181–184

    Google Scholar 

  76. Dockter J, Schroder A, Eaton B et al (2009) Analytical characterization of the APTIMA HPV Assay. J Clin Virol 45(Suppl 1):S39–S47

    Article  PubMed  CAS  Google Scholar 

  77. Getman D, Aiyer A, Dockter J, Giachetti C, Zhang F, Ginocchio CC (2009) Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets. J Clin Virol 45(Suppl 1):S49–S54

    Article  PubMed  CAS  Google Scholar 

  78. Dockter J, Schroder A, Hill C, Guzenski L, Monsonego J, Giachetti C (2009) Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions. J Clin Virol 45(Suppl 1):S55–S61

    Article  PubMed  CAS  Google Scholar 

  79. Wu R, Belinson SE, Du H et al (2010) Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I. Int J Gynecol Cancer 20:1411–1414

    Article  PubMed  Google Scholar 

  80. Monsonego J, Hudgens MG, Zerat L et al (2011) Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study. Int J Cancer 129:691–701

    Article  PubMed  CAS  Google Scholar 

  81. Clarke MA, Wentzensen N, Mirabello L et al (2012) Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer. Cancer Epidemiol Biomarkers Prev 21:12 2125–2137

    Google Scholar 

  82. Wentzensen N, Sherman ME, Schiffman M, Wang SS (2009) Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 112:293–299

    Article  PubMed  CAS  Google Scholar 

  83. Saha B, Chaiwun B, Tsao-Wei DD et al (2007) Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions. Int J Gynecol Pathol 26:214–222

    Article  PubMed  Google Scholar 

  84. Tsoumpou I, Arbyn M, Kyrgiou M et al (2009) p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis. Cancer Treat Rev 35:210–220

    Article  PubMed  CAS  Google Scholar 

  85. Schmidt D, Bergeron C, Denton KJ, Ridder R (2011) p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study. Cancer Cytopathol 119:158–166

    Article  PubMed  Google Scholar 

  86. Ravarino A, Nemolato S, Macciocu E et al (2012) CINtec PLUS immunocytochemistry as a tool for the cytologic diagnosis of glandular lesions of the cervix uteri. Am J Clin Pathol 138:652–656

    Article  PubMed  Google Scholar 

  87. Samarawardana P, Singh M, Shroyer KR (2011) Dual stain immunohistochemical localization of p16INK4A and ki-67: a synergistic approach to identify clinically significant cervical mucosal lesions. Appl Immunohistochem Mol Morphol 19:514–518

    Article  PubMed  CAS  Google Scholar 

  88. Renshaw AA (2002) Measuring sensitivity in gynecologic cytology: a review. Cancer 96:210–217

    Article  PubMed  Google Scholar 

  89. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 188:1383–1392 (2003)

    Google Scholar 

  90. Cibas ES (2008) Laboratory management. In: Cibas ES, Ducatman BS (eds) Cytology, diagnostic principles and clinical correlates, 3rd edn. Saunders, Philadelphia, pp 495–522

    Google Scholar 

  91. American College of Obstetricians and Gynecologists (2012) Screening for Cervical Cancer. Practice Bulletin No. 131. Obstet Gynecol 120:1222–1238

    Google Scholar 

  92. Massad LS, Einstein MH, Huh WK et al. (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursor. J Low Genit Tract Dis 17(5):S1–S27

    Google Scholar 

  93. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249

    Article  PubMed  Google Scholar 

  94. Sherman ME (2000) Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13:295–308

    Article  PubMed  CAS  Google Scholar 

  95. Koornstra JJ, Mourits MJ, Sijmons RH, Leliveld AM, Hollema H, Kleibeuker JH (2009) Management of extracolonic tumours in patients with Lynch syndrome. Lancet Oncol 10:400–408

    Article  PubMed  CAS  Google Scholar 

  96. Sonoda Y, Barakat RR (2006) Screening and the prevention of gynecologic cancer: endometrial cancer. Best Pract Res Clin Obstet Gynaecol 20:363–377

    Article  PubMed  Google Scholar 

  97. Guidos BJ, Selvaggi SM (2000) Detection of endometrial adenocarcinoma with the ThinPrep Pap test. Diagn Cytopathol 23:260–265

    Article  PubMed  CAS  Google Scholar 

  98. Schorge JO, Hossein Saboorian M, Hynan L, Ashfaq R (2002) ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Cancer 96:338–343

    Article  PubMed  Google Scholar 

  99. Greenspan DL, Cardillo M, Davey DD, Heller DS, Moriarty AT (2006) Endometrial cells in cervical cytology: review of cytological features and clinical assessment. J Low Genit Tract Dis 10:111–122

    Article  PubMed  Google Scholar 

  100. de Peralta-Venturino MN, Purslow MJ, Kini SR (1995) Endometrial cells of the “lower uterine segment” (LUS) in cervical smears obtained by endocervical brushings: a source of potential diagnostic pitfall. Diagn Cytopathol 12:263–268; discussion 8–71

    Google Scholar 

  101. Solomon D, Davey D, Kurman R et al (2002) The Bethesda System 2001: terminology for reporting the results of cervical cytology. JAMA 287:2114–2119

    Article  PubMed  Google Scholar 

  102. Kipp BR, Medeiros F, Campion MB et al (2008) Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study. Cancer 114:228–235

    Article  PubMed  Google Scholar 

  103. Dijkhuizen FP, Mol BW, Brolmann HA, Heintz AP (2000) The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 89:1765–1772

    Article  PubMed  CAS  Google Scholar 

  104. Creasman W (2009) Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 105:109

    Article  PubMed  Google Scholar 

  105. Fadare O, Mariappan MR, Hileeto D, Wang S, McAlpine JN, Rimm DL (2005) Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol 18:673–680

    Article  PubMed  Google Scholar 

  106. Jorns JM, Knoepp SM (2009) Occult fallopian tube carcinoma detected in routine pelvic washing specimens submitted for staging: another justification for pelvic washing cytology? Diagn Cytopathol 37:923–929

    Article  PubMed  Google Scholar 

  107. Lin O (2009) Challenges in the interpretation of peritoneal cytologic specimens. Arch Pathol Lab Med 133:739–742

    PubMed  Google Scholar 

  108. Bristow RE, Purinton SC, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL 2nd (2006) Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Gynecol Oncol 103:709–713

    Article  PubMed  Google Scholar 

  109. Cooper AL, Dornfeld-Finke JM, Banks HW, Davey DD, Modesitt SC (2006) Is cytologic screening an effective surveillance method for detection of vaginal recurrence of uterine cancer? Obstet Gynecol 107:71–76

    Article  PubMed  Google Scholar 

  110. Myers ER, Bastian LA, Havrilesky LJ et al (2006) Management of adnexal mass. Evid Rep Technol Assess (Full Rep) 130:1–145

    Google Scholar 

  111. Brown DL (2007) A practical approach to the ultrasound characterization of adnexal masses. Ultrasound Q 23:87–105

    Article  PubMed  Google Scholar 

  112. Gostout BS, Brewer MA (2006) Guidelines for referral of the patient with an adnexal mass. Clin Obstet Gynecol 49:448–458

    Article  PubMed  Google Scholar 

  113. Bibbo M, Wood MD, Fitzpatrick BT (2008) Peritoneal washings and ovary. In: Bibbo M, Wilbur DC (eds) Comprehensive cytopathology, 3rd edn. Elsevier, Amsterdam, pp 291–301

    Chapter  Google Scholar 

  114. Davidson B, Risberg B, Kristensen G et al (1999) Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers. Virchows Arch 435:43–49

    Article  PubMed  CAS  Google Scholar 

  115. Selvaggi SM (2003) Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis. Diagn Cytopathol 28:335–341

    Article  PubMed  Google Scholar 

  116. Zuna RE, Mitchell ML (1988) Cytologic findings in peritoneal washings associated with benign gynecologic disease. Acta Cytol 32:139–147

    PubMed  CAS  Google Scholar 

  117. Lowe E, McKenna H (1989) Peritoneal washing cytology: a retrospective analysis of 175 gynaecological patients. Aust N Z J Obstet Gynaecol 29:55–61

    Article  PubMed  CAS  Google Scholar 

  118. Zuna RE, Mitchell ML, Mulick KA, Weijchert WM (1989) Cytohistologic correlation of peritoneal washing cytology in gynecologic disease. Acta Cytol 33:327–336

    PubMed  CAS  Google Scholar 

  119. Zuna RE, Behrens A (1996) Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J Natl Cancer Inst 88:980–987

    Article  PubMed  CAS  Google Scholar 

  120. Fadare O, Mariappan MR, Wang S, Hileeto D, McAlpine J, Rimm DL (2004) The histologic subtype of ovarian tumors affects the detection rate by pelvic washings. Cancer 102:150–156

    Article  PubMed  Google Scholar 

  121. Kudo R, Takashina T, Ito E et al (1990) Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients. Acta Cytol 34:545–548

    PubMed  CAS  Google Scholar 

  122. Zanetta G, Trio D, Lissoni A et al (1993) Early and short-term complications after US-guided puncture of gynecologic lesions: evaluation after 1,000 consecutive cases. Radiology 189:161–164

    PubMed  CAS  Google Scholar 

  123. Ganjei P (1995) Fine-needle aspiration cytology of the ovary. Clin Lab Med 15:705–726

    PubMed  CAS  Google Scholar 

  124. Davila RM (1993) Cytology of benign cystic uterine adnexal masses. Acta Cytol 37:385–390

    PubMed  CAS  Google Scholar 

  125. Higgins RV, Matkins JF, Marroum MC (1999) Comparison of fine-needle aspiration cytologic findings of ovarian cysts with ovarian histologic findings. Am J Obstet Gynecol 180:550–553

    Article  PubMed  CAS  Google Scholar 

  126. Lu D, Davila RM, Pinto KR, Lu DW (2004) ThinPrep evaluation of fluid samples aspirated from cystic ovarian masses. Diagn Cytopathol 30:320–324

    Article  PubMed  Google Scholar 

  127. Wojcik EM, Selvaggi SM (1992) Diagnostic accuracy of fine-needle aspiration cytology in persistent or recurrent gynecologic malignancies. Diagn Cytopathol 8:322–326

    Article  PubMed  CAS  Google Scholar 

  128. Angstrom T, Kjellgren O, Bergman F (1972) The cytologic diagnosis of ovarian tumors by means of aspiration biopsy. Acta Cytol 16(4):336–341

    Google Scholar 

  129. Mulvany NJ (1996) Aspiration cytology of ovarian cysts and cystic neoplasms. A study of 235 aspirates. Acta Cytol 40:911–920

    Article  PubMed  CAS  Google Scholar 

  130. Mulvany N, Ostor A, Teng G (1995) Evaluation of estradiol in aspirated ovarian cystic lesions. Acta Cytol 39:663–668

    PubMed  CAS  Google Scholar 

  131. Yee H, Greenebaum E, Lerner J, Heller D, Timor-Tritsch IE (1994) Transvaginal sonographic characterization combined with cytologic evaluation in the diagnosis of ovarian and adnexal cysts. Diagn Cytopathol 10:107–112

    Article  PubMed  CAS  Google Scholar 

  132. Allias F, Chanoz J, Blache G, Thivolet-Bejui F, Vancina S (2000) Value of ultrasound-guided fine-needle aspiration in the management of ovarian and paraovarian cysts. Diagn Cytopathol 22:70–80

    Article  PubMed  CAS  Google Scholar 

  133. Lipitz S, Seidman DS, Menczer J et al (1992) Recurrence rate after fluid aspiration from sonographically benign-appearing ovarian cysts. J Reprod Med 37:845–848

    PubMed  CAS  Google Scholar 

  134. Zanetta G, Lissoni A, Torri V et al (1996) Role of puncture and aspiration in expectant management of simple ovarian cysts: a randomised study. BMJ 313:1110–1113

    Article  PubMed  CAS  Google Scholar 

  135. Fisch JD, Sher G (2004) Sclerotherapy with 5% tetracycline is a simple alternative to potentially complex surgical treatment of ovarian endometriomas before in vitro fertilization. Fertil Steril 82:437–441

    Article  PubMed  CAS  Google Scholar 

  136. Kafali H, Yurtseven S, Atmaca F, Ozardali I (2003) Management of non-neoplastic ovarian cysts with sclerotherapy. Int J Gynaecol Obstet 81:41–45

    Article  PubMed  CAS  Google Scholar 

  137. Mesogitis S, Daskalakis G, Pilalis A et al (2005) Management of ovarian cysts with aspiration and methotrexate injection. Radiology 235:668–673

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Massachusetts General Hospital, Warren 105/55 Fruit Street, Boston, MA, 02114, USA

    Rosemary Tambouret

Authors
  1. Rosemary Tambouret
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rosemary Tambouret .

Editor information

Editors and Affiliations

  1. Feinberg School of Medicine Northwestern University, Chicago, Illinois, USA

    Ritu Nayar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tambouret, R. (2014). Female Genital Tract. In: Nayar, R. (eds) Cytopathology in Oncology. Cancer Treatment and Research, vol 160. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-38850-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-38850-7_10

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-38849-1

  • Online ISBN: 978-3-642-38850-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation